Suspected herbal hepatotoxicity: Requirements for appropriate causality assessment by the US pharmacopeia

Drug Safety

Volumn 35, Issue 12, 2012, Pages 1091-1097

  Teschke, Rolf ^a   Schulze, Johannes ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Herbal medicines; Liver disorders; Liver injury

Indexed keywords

HERBACEOUS AGENT;

ALGORITHM; COUNCIL FOR INTERNATIONAL ORGANIZATION OF MEDICAL SCIENCES SCALE; DRUG SURVEILLANCE PROGRAM; HUMAN; LIVER TOXICITY; MEDICAL LITERATURE; NARANJO SCALE; PRIORITY JOURNAL; REVIEW; VALIDITY; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER; PHARMACOPOEIAS AS TOPIC; PLANT PREPARATIONS; RISK ASSESSMENT; UNITED STATES;

EID: 84862015812     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11631960-000000000-00000     Document Type: Review

References (39)

1. Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009; 29: 373-82
2. Liss G, Lewis JH. Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol 2009; 5: 843-60
3. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007; 25: 1135-51 (Pubitemid 46650295)
4. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-66
5. Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Regul Toxicol Pharmacol 2011; 59: 1-7
6. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to druginduced liver injuries. J Clin Epidemiol 1993; 46: 1323-30 (Pubitemid 23333873)
7. Agarwal VK, McHutchison JG, Hoofnagle JH. Important elements for the diagnosis of drug-induced liver injury. Drug-Induced Liver Injury Network. Clin Gastroenterol Hepatol 2010; 8: 463-47
8. Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Saf 2008; 31: 469-84 (Pubitemid 351693681)
9. Mahady GB, Low Dog T, Barrett ML, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628-38
10. Teschke R, Schmidt-Taenzer W, Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf 2011; 20: 567-82
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45 (Pubitemid 12149145)
12. Naser B, Schnitker J, Minkin MJ, et al. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011; 18: 366-75
13. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). Issued May 8, 2007 [online]. Available from URL: http://www.ema.eur opa.eu/docs/en-GB/document-library/ Herbal-HMPC-as sessment-report/2010/02/WC500074167.pdf [Accessed 2011 Nov 18]
14. Rochon J, Protiva P, Seeff LB, et al., for the Drug-Induced Liver Injury Network (DILIN). Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008; 48: 1175-83
15. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Drug-Induced Liver Injury Network (DILIN). Gastroenterology 2008; 135: 1924-34
16. Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs: II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6 (Pubitemid 23333874)
17. Teschke R. Black cohosh and suspected hepatotoxicityinconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review. Menopause 2010; 17: 426-40
18. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, et al. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol 2011; 11: 249-59
19. Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol 2011; 61: 282-91
20. Teschke R, Glass X, Schulze J, et al. Suspected greater celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012; 24: 270-80
21. Lucena MI, Camargo R, Andrade RJ, et al. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001; 33: 123-30 (Pubitemid 32016894)
22. Andrade RJ, Lucena MI, Fernández MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Spanish Group for the Study of Drug-induced Liver Disease. Gastroenterology 2005; 129: 512-21 (Pubitemid 41096639)
23. García-Corté s M, Lucena MI, Pachkoria K, et al. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008; 27: 780-9 (Pubitemid 351490076)
24. Rockey DC, Seeff LB, Rochon J, et al., for the US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010; 51: 2117-26
25. Miljkovic MM, Dobric S, Dragojevic-Simic V. Consistency between causality assessments obtained with two scales and their agreement with clinical judgements in hepatotoxicity. Pharmacoepidemiol Drug Saf 2011; 20: 272-85
26. Miljkovic MM, Dobric S, Dragojevic-Simic V. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity. J Clin Pharm Ther 2012; 37: 196-203
27. García-Corté s M, Stephens C, Lucena MI, et al., on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011; 55: 683-91
28. Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 2001; 33: 308-10 (Pubitemid 32016915)
29. Gunawan B, Kaplowitz N. Clinical perspectives on xenobioticinduced hepatotoxicity. Drug Metab Rev 2004; 36: 301-12
30. Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481-9 (Pubitemid 41061102)
31. Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: long term follow-up in a hepatotoxicity registry. Hepatology 2006; 44: 1581-8 (Pubitemid 44953663)
32. García-Corté s M, Lucena MI, Andrade RJ, et al. Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity? Ann Pharmacother 2004; 38: 1540-1 (Pubitemid 39100217)
33. Fontana RJ, Watkins PB, Bonkovsky HL, et al., for the DILIN Study Group. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32: 55-68
34. Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52: 730-42
35. Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol 2010; 105: 1561-6
36. Teschke R, Frenzel C, Schulze J, et al. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012; 63: 1-9
37. Teschke R, Frenzel C, Wolff A, et al. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvements. Ann Hepatol 2012; 11: 500-12
38. Stammschulte T, Gundert-Remy U. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained [letter]? Regul Toxicol Pharmacol. Epub 2012 Jun 20
39. Teschke R, Frenzel C, Schulze J, et al. Suspected herbal hepatotoxicity: the pharmacovigilance dilemma with disputed and obsolete evaluation methods. Regul Toxicol Pharmacol. Epub 2012 Jun 22